for a genetic defect in autistic males. Furthermore, a recent study using DNA probes has found genetic alterations (i.e., deletions) in Lesch-Nyhan syndrome (Yang, Patel, Chinault, Stout, Jackson, Hildebrand, & Caskey, 1984) , an X-linked disease with considerable overlapping symptoms with autism. For the present study, we reasoned that the most productive region to search for submicroscopic structural abnormalities (i.e., deletions) would be in the Xq26-q28 region because the fragile site has been mapped to Xq27.3. Of course, it is also possible that genetic alterations that contributed to the autistic syndrome would be found in other regions or chromosomes. A number of DNA probes in the Xq26-q28 region have been developed, and this paper reports the use of six of these to study the X chromosome of two boys (ages 13 and 17, respectively) with both autism and the fragile X chromosome.
The 2 patients were identified through a study of X chromosome abnormalities in autistic boys in which 20 subjects were karyotyped, and 2, the subjects of these case reports, were found to have a fragile X site. Patient A was originally evaluated at age 3 years 9 months, and Patient B at age Kanner's (1943) criteria for infantile autism. Their records were reviewed for the present study by one of us (L.Y.T.), and both the patients satisfied DSM-III criteria (American Psychiatric Association, 1980) for Pervasive Developmental Disorder-Infantile Autism. When they participated in the present study, they were attending autism classrooms for trainable students in local public schools.
Lymphocyte cultures from the patients' blood were set up in medium TC 199 with 5~ fetal calf serum according to the procedure of Sutherland (1979) . The cells were processed for chromosome analysis after 96 hours of culturing.
A folic acid fragile site at Xq27 was confirmed by two independent karyotypes (in both Patients A and B). We examined the Xq26-q28 region using six DNA probes, comparing the patients with the remaining 18 autistic subjects without fragile sites and three normal controls. The six probes and their locations were two Factor VIII probes (625.1 and 625.8; Xq28) (Gitsckier et al., 1984) , glucose-6-phosphate dehydrogenase (G6PD; Xq28) (Toniolo et al., 1984) , hypoxanthine phosphoribosyl transferase (HPRT: Xq26-q27.3) (Brennand, Konecki, & Caskey, 1983) , and two anonymous probes DXS52 (ST 14.1) (Xq28) (Oberle, Brayna, Camerino, White, & Man- Table I del, 1985) and MN12 (Xq28) (Patterson et al. 1987) . These probes flank the fragile site at Xq27.3. Genomic DNA was extracted from buffy coat preparations using the phenol/chloroform extraction procedure and digested with three restriction enzymes, according to specifications recommended by the supplier (BRL); XhoI, KpnI, and BamHI. The rationale for the choice of enzymes was to produce large fragment sizes in order to maximize the probability that a deletion, if present, would overlap one of the fragments. The DNA was electrophoresed on 15 • 30 cm, 0.4~ agarose gels at 40 mA for 72 hours, transferred to Zetabind membranes by Southern blotting, and hybridized with the probes labeled with P32dCTP by the random primer method. The blots were given three 5-minute, room temperature, low-stringency (2 X SSC) washes, followed by three 10-minute, 55 C, high-stringency (0.1 X SSC) washes, and autoradiographed for 48 hours at -80 C with Kodak XAR-5 film and Cronex image intensifier screens.
The results are summarized in Table I . A plus sign indicates that the patients had the same pattern of bands as the comparison subjects, and N indicates that the autoradiograph was not interpretable for technical reasons. Whenever an autoradiograph was uninterpretable, it was repeated, and if an interpretable autoradiograph was not obtained on the second attempt, it was scored as N. Interpretable results were obtained for each probe with at least one enzyme and no evidence of a deletion (missing or displaced bands) was found.
Although it appears that from this study so far there are no clinically useful markers for autism, it should be pointed out that the mother and the brother of Patient A were negative for fragile X chromosome. (Mother and siblings of patient B have not been tested yet for fragile X.) More families, particularly those with multiple incidence of fragile X syndrome, should be studied. Furthermore, in the present study, only six probes were used. With the availability of a growing number of probes to the Xq26-q28 region in future investigations one can be confident that if deletions are present, they would be detected.
